Revvity, Inc. (RVTY)

130.22 -0.41 (-0.31%) USD  |  NYSE  |  Sep 04, 16:00
130.65 +0.43 (+0.33%) Pre-Market: 20:00
More

Revvity SG&A Expense (TTM) : 1.026B for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for RVTY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.026B
March 31, 2026 996.05M
December 31, 2025 991.89M
September 30, 2025 984.49M
June 30, 2025 980.10M
March 31, 2025 983.22M
December 31, 2024 994.07M
September 30, 2024 1.006B
June 30, 2024 1.019B
March 31, 2024 1.035B
December 31, 2023 1.023B
September 30, 2023 1.010B
June 30, 2023 999.87M
March 31, 2023 996.04M
December 31, 2022 1.082B
September 30, 2022 1.121B
June 30, 2022 1.157B
March 31, 2022 1.175B
December 31, 2021 1.092B
September 30, 2021 1.072B
June 30, 2021 1.022B
March 31, 2021 960.74M
December 31, 2020 917.89M
September 30, 2020 865.58M
June 30, 2020 844.50M
Date Value
March 31, 2020 825.03M
December 31, 2019 815.32M
September 30, 2019 815.12M
June 30, 2019 805.22M
March 31, 2019 806.04M
December 31, 2018 806.91M
September 30, 2018 772.75M
June 30, 2018 729.34M
March 31, 2018 675.02M
December 31, 2017 622.30M
September 30, 2017 608.72M
June 30, 2017 600.46M
March 31, 2017 603.36M
December 31, 2016 600.88M
September 30, 2016 596.60M
June 30, 2016 601.72M
March 31, 2016 597.51M
December 31, 2015 598.85M
September 30, 2015 656.99M
June 30, 2015 652.26M
March 31, 2015 652.77M
December 31, 2014 660.10M
September 30, 2014 585.40M
June 30, 2014 586.06M
March 31, 2014 587.56M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Agilent Technologies, Inc. 1.844B
Thermo Fisher Scientific, Inc. 8.653B
Danaher Corp. 7.949B
Waters Corp. 1.246B
Bio-Rad Laboratories, Inc. 852.20M